http://www.mail.com/subjects/29636-diabetes.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png http://www.mail.com/subjects/29636-diabetes.html http://www.mail.com/scitech/health/2100006-france-drugmaker-trial-suspected-deaths.html NANTERRE, France (AP) — The makers of a diabetes and weight loss drug suspected in the deaths of hundreds of people went on trial Tuesday, facing charges they misled the public about the product's safety. But after years of delays in one of France's biggest recent health scandals, the proceedings could still be pushed back further. Between 1976 and 2009, ... Tue, 21 May 2013 17:38:31 GMT http://www.mail.com/scitech/health/2100006-france-drugmaker-trial-suspected-deaths.html 2013-05-21T17:38:31Z http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html Merck & Co. on Wednesday posted disappointing first-quarter results and cut its earnings forecast for the year. But the world's third-largest drugmaker predicted that things would soon improve. Merck was slammed by two factors plaguing most of its rivals: growing competition from generic drugs and unfavorable exchange rates. Major drugmakers in recent yea... Wed, 01 May 2013 20:56:47 GMT http://www.mail.com/business/economy/2055676-generic-competition-cuts-mercks-q1-sales-profit.html 2013-05-01T20:56:47Z http://www.mail.com/scitech/health/2044466-newfound-hormone-holds-hope-diabetes-treatment.html NEW YORK (AP) — Scientists have identified a hormone that can sharply boost the number of cells that make insulin in mice, a discovery that may someday lead to a treatment for the most common type of diabetes. People have their own version of this hormone, and the new work suggests that giving diabetics more might one day help them avoid insulin shots. Th... Thu, 25 Apr 2013 16:16:20 GMT http://www.mail.com/scitech/health/2044466-newfound-hormone-holds-hope-diabetes-treatment.html 2013-04-25T16:16:20Z http://www.mail.com/business/economy/2022746-jj-1q-profit-falls-10-pct-despite-higher-sales.html Johnson & Johnson's first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and administration, plus charges for litigation and other items. The maker of No More Tears baby shampoo, prescription drugs and surgical tools said Tuesday repeatedly during a conference call with analysts that re... Tue, 16 Apr 2013 20:17:59 GMT http://www.mail.com/business/economy/2022746-jj-1q-profit-falls-10-pct-despite-higher-sales.html 2013-04-16T20:17:59Z http://www.mail.com/scitech/health/2016692-fda-reviewing-heart-risks-glaxo-diabetes-pill.html WASHINGTON (AP) — The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was severely restricted in 2010 due to concerns about its impact on the heart. Regulators announced the highly unusual move in a government notice published on Friday. The FDA said it will ask a ... Fri, 12 Apr 2013 21:17:53 GMT http://www.mail.com/scitech/health/2016692-fda-reviewing-heart-risks-glaxo-diabetes-pill.html 2013-04-12T21:17:53Z http://www.mail.com/scitech/health/1997134-walgreen-clinics-expand-care-chronic-illness.html Walgreen Co. has stretched the reach of its drugstore clinics beyond treating ankle sprains and sinus infections to handling chronic diseases such as diabetes, asthma and high blood pressure. The company, based in Deerfield, Ill., said Thursday that most of its roughly 370 in-store Take Care Clinics now will diagnose, treat and monitor patients with some ... Thu, 04 Apr 2013 15:17:36 GMT http://www.mail.com/scitech/health/1997134-walgreen-clinics-expand-care-chronic-illness.html 2013-04-04T15:17:36Z http://www.mail.com/scitech/health/1987128-fda-oks-first-of-its-kind-diabetes-drug-jj.html WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine. The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes, which affects an estimated 26 million Americans. The once-a-day medicatio... Fri, 29 Mar 2013 19:39:49 GMT http://www.mail.com/scitech/health/1987128-fda-oks-first-of-its-kind-diabetes-drug-jj.html 2013-03-29T19:39:49Z http://www.mail.com/scitech/health/1954684-fda-probes-pancreas-risks-with-diabetes-drugs.html WASHINGTON (AP) — The Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems. The agency said Thursday samples of pancreas tissue taken from a small number of patients showed inflammation and cellular changes that often precede cancer. Aca... Thu, 14 Mar 2013 20:21:27 GMT http://www.mail.com/scitech/health/1954684-fda-probes-pancreas-risks-with-diabetes-drugs.html 2013-03-14T20:21:27Z http://www.mail.com/scitech/health/1936586-women-diabetes-care-when-pregnant.html WASHINGTON (AP) — A change in testing could nearly triple the number of women diagnosed with diabetes during pregnancy, but would catching milder cases help mother or baby? A government panel is urging more research to find that out before doctors make the switch. Gestational diabetes — the kind that strikes during pregnancy — is a growing problem. More w... Wed, 06 Mar 2013 22:11:18 GMT http://www.mail.com/scitech/health/1936586-women-diabetes-care-when-pregnant.html 2013-03-06T22:11:18Z http://www.mail.com/scitech/health/1883090-novo-nordisk-us-shares-skid-drug-review-setback.html Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years. The company said Sunday that the Food and Drug Administration wants to see information from a study that looks at cardiovascular he... Mon, 11 Feb 2013 14:18:00 GMT http://www.mail.com/scitech/health/1883090-novo-nordisk-us-shares-skid-drug-review-setback.html 2013-02-11T14:18:00Z http://www.mail.com/scitech/health/1882018-novo-nordisk-fda-rejects-insulin-drugs.html NEW YORK (AP) — Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes. The Danish drugmaker says it received a "complete response letter" from the FDA regarding its applications for approval of Tresiba and Ryzodeg, or insulin degludec, on Friday. Such a letter indicates... Sun, 10 Feb 2013 22:27:00 GMT http://www.mail.com/scitech/health/1882018-novo-nordisk-fda-rejects-insulin-drugs.html 2013-02-10T22:27:00Z http://www.mail.com/scitech/health/1802220-poll-americans-risks-obesity.html WASHINGTON (AP) — Heart disease and diabetes get all the attention, but what about the many other ways obesity can damage your health? Carrying too many pounds may lead to or worsen some types of cancer, arthritis, sleep apnea, even infertility. But a new poll suggests few Americans realize the links. Only about one-quarter of people think it's possible f... Mon, 07 Jan 2013 08:19:00 GMT http://www.mail.com/scitech/health/1802220-poll-americans-risks-obesity.html 2013-01-07T08:19:00Z http://www.mail.com/scitech/health/1756858-apnewsbreak-sotomayor-book-offers-personal.html WASHINGTON (AP) — Supreme Court Justice Sonia Sotomayor says in her upcoming memoir that her lifelong battle against diabetes and the fear that she might die early played a big part in her decision not to have children. The 58-year-old Sotomayor says in an unusually personal book for a Supreme Court justice that she feels an occasional tug of regret at no... Tue, 11 Dec 2012 06:47:00 GMT http://www.mail.com/scitech/health/1756858-apnewsbreak-sotomayor-book-offers-personal.html 2012-12-11T06:47:00Z